RE:RE:RE:RE:RE:RE:RE:RE:ONCY to make an "Oral Presentation" on Bracelet-1 at ASCOBecause strategic delaying tactics are a part of large valuation deals involving multiple parties as witnessed in the US$43 Billion acquisition deal that Pfizer made for Seagen.